Improved Outcome of Biliary Atresia with Postoperative High-Dose Steroid

Objective. The dosage, duration, and the benefits of high-dose steroid treatment and outcome in biliary atresia (BA) remain controversial. In this study, we evaluated the impact of high-dose steroid therapy on the outcome of BA after the Kasai procedure. Methods. Intravenous prednisolone administrat...

Full description

Saved in:
Bibliographic Details
Main Authors: Rui Dong, Zai Song, Gong Chen, Shan Zheng, Xian-min Xiao
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:Gastroenterology Research and Practice
Online Access:http://dx.doi.org/10.1155/2013/902431
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832556631838162944
author Rui Dong
Zai Song
Gong Chen
Shan Zheng
Xian-min Xiao
author_facet Rui Dong
Zai Song
Gong Chen
Shan Zheng
Xian-min Xiao
author_sort Rui Dong
collection DOAJ
description Objective. The dosage, duration, and the benefits of high-dose steroid treatment and outcome in biliary atresia (BA) remain controversial. In this study, we evaluated the impact of high-dose steroid therapy on the outcome of BA after the Kasai procedure. Methods. Intravenous prednisolone administration was started 1 week after surgery, followed by 8 to 12 weeks of oral prednisolone. Total bilirubin (TB) levels (3, 6, and 12 months after surgery), early onset of cholangitis, and two-year native liver survival were evaluated. Results. 53.4%, 56.9%, and 58.1% of the patients in the high-dose steroid group were jaundice-free 3, 6, and 12 months after surgery, respectively; these values were significantly higher than the 38.7%, 39.4%, and 43.3% of the low-dose steroid group. One year after surgery, the incidence of cholangitis in the high-dose group (32.0%) was lower than that in the low-dose group (48.0%). Infants with native liver in the high-dose group had a better two-year survival compared to those in the low-dose steroid group (53.7% versus 42.6%). Conclusions. The high-dose steroid protocol can reduce the incidence of cholangitis, increase the jaundice-free rate, and improve two-year survival with native liver after the Kasai operation.
format Article
id doaj-art-b13402abf3294c6ea1dcccef468457ee
institution Kabale University
issn 1687-6121
1687-630X
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series Gastroenterology Research and Practice
spelling doaj-art-b13402abf3294c6ea1dcccef468457ee2025-02-03T05:44:54ZengWileyGastroenterology Research and Practice1687-61211687-630X2013-01-01201310.1155/2013/902431902431Improved Outcome of Biliary Atresia with Postoperative High-Dose SteroidRui Dong0Zai Song1Gong Chen2Shan Zheng3Xian-min Xiao4Department of Pediatric Surgery, Children’s Hospital of Fudan University, and Key Laboratory of Neonatal Disease, Ministry of Health, 399 Wan Yuan Road, Shanghai 201102, ChinaDepartment of Pediatric Surgery, Children’s Hospital of Fudan University, and Key Laboratory of Neonatal Disease, Ministry of Health, 399 Wan Yuan Road, Shanghai 201102, ChinaDepartment of Pediatric Surgery, Children’s Hospital of Fudan University, and Key Laboratory of Neonatal Disease, Ministry of Health, 399 Wan Yuan Road, Shanghai 201102, ChinaDepartment of Pediatric Surgery, Children’s Hospital of Fudan University, and Key Laboratory of Neonatal Disease, Ministry of Health, 399 Wan Yuan Road, Shanghai 201102, ChinaDepartment of Pediatric Surgery, Children’s Hospital of Fudan University, and Key Laboratory of Neonatal Disease, Ministry of Health, 399 Wan Yuan Road, Shanghai 201102, ChinaObjective. The dosage, duration, and the benefits of high-dose steroid treatment and outcome in biliary atresia (BA) remain controversial. In this study, we evaluated the impact of high-dose steroid therapy on the outcome of BA after the Kasai procedure. Methods. Intravenous prednisolone administration was started 1 week after surgery, followed by 8 to 12 weeks of oral prednisolone. Total bilirubin (TB) levels (3, 6, and 12 months after surgery), early onset of cholangitis, and two-year native liver survival were evaluated. Results. 53.4%, 56.9%, and 58.1% of the patients in the high-dose steroid group were jaundice-free 3, 6, and 12 months after surgery, respectively; these values were significantly higher than the 38.7%, 39.4%, and 43.3% of the low-dose steroid group. One year after surgery, the incidence of cholangitis in the high-dose group (32.0%) was lower than that in the low-dose group (48.0%). Infants with native liver in the high-dose group had a better two-year survival compared to those in the low-dose steroid group (53.7% versus 42.6%). Conclusions. The high-dose steroid protocol can reduce the incidence of cholangitis, increase the jaundice-free rate, and improve two-year survival with native liver after the Kasai operation.http://dx.doi.org/10.1155/2013/902431
spellingShingle Rui Dong
Zai Song
Gong Chen
Shan Zheng
Xian-min Xiao
Improved Outcome of Biliary Atresia with Postoperative High-Dose Steroid
Gastroenterology Research and Practice
title Improved Outcome of Biliary Atresia with Postoperative High-Dose Steroid
title_full Improved Outcome of Biliary Atresia with Postoperative High-Dose Steroid
title_fullStr Improved Outcome of Biliary Atresia with Postoperative High-Dose Steroid
title_full_unstemmed Improved Outcome of Biliary Atresia with Postoperative High-Dose Steroid
title_short Improved Outcome of Biliary Atresia with Postoperative High-Dose Steroid
title_sort improved outcome of biliary atresia with postoperative high dose steroid
url http://dx.doi.org/10.1155/2013/902431
work_keys_str_mv AT ruidong improvedoutcomeofbiliaryatresiawithpostoperativehighdosesteroid
AT zaisong improvedoutcomeofbiliaryatresiawithpostoperativehighdosesteroid
AT gongchen improvedoutcomeofbiliaryatresiawithpostoperativehighdosesteroid
AT shanzheng improvedoutcomeofbiliaryatresiawithpostoperativehighdosesteroid
AT xianminxiao improvedoutcomeofbiliaryatresiawithpostoperativehighdosesteroid